SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Array Biopharma, Inc
An SI Board Since March 2005
Posts SubjectMarks Bans Symbol
321 29 0 ARRY
Emcee:  keokalani'nui Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
96Array Biopharma: A Wall Street Anomaly by: Ohad Hammer October 4, 2010 Arraysim1-10/4/2010
95Here's an interesting excerpt from a two and a half year old article on CELGsim1-10/4/2010
94yeeeeeeeeeeeeeeeeeeeeeeeeeeeeeees!........scaram(o)uche-10/2/2010
93Array BioPharma Announces Positive Results for HER2 Inhibitor, ARRY-380, in Breasim1-10/1/2010
92Signal Genetics Announces Partnership with Array BioPharma to Advance a Multiplescaram(o)uche-9/22/2010
91I commented on this in siliconinvestor.com and previously noted that I think theDewDiligence_on_SI-9/15/2010
90Not a big part of the business plan, and lots of "ifs" ass'd with scaram(o)uche-9/15/2010
89Cancer Immunol Immunother. 2010 Sep 4. [Epub ahead of print] In acute myeloid lscaram(o)uche-9/5/2010
88Mol Cancer Ther. 2010 Jun 29. [Epub ahead of print] Identification of Common Prscaram(o)uche-7/2/2010
87Mol Cancer Ther. 2010 Jun 22. [Epub ahead of print] Mcl-1 Stability Determines scaram(o)uche-6/25/2010
86Array BioPharma's ARRY-520 Well Tolerated and Demonstrates Preliminary Activscaram(o)uche-6/5/2010
85Cancer Res. 2010 May 18. [Epub ahead of print] Activation of FOXO3a Is Sufficiescaram(o)uche-5/24/2010
84Array BioPharma Announces Abstracts Selected for Presentation at 2010 ASCO Annuascaram(o)uche-5/20/2010
83From Dew's Ihub thread <i> Notes 1. The recent NVS deal wherein ARRtom pope-5/5/2010
82Seemed like decent results to me, tepid response. May be the results were pricedtom pope-5/4/2010
81Press Release Source: Array BioPharma Inc. On Monday May 3, 2010, 4:30 pm EDT Btom pope-5/4/2010
80nuggets!...... >> Genentech collaboration: Array received $3.75 million scaram(o)uche-5/3/2010
79OK, this wonderful business plan, part luck, mostly skill, is getting no respectscaram(o)uche-4/26/2010
78not much here from an investment angle, but may be useful to someone so I'llscaram(o)uche-4/23/2010
77162 was obviously of great value, but it wasn't a small company project. Itscaram(o)uche-4/22/2010
76UBS downgrade, buy to neutral. I'm on a different page. Love the Novartis scaram(o)uche-4/22/2010
75Astra, Merck and Novartis...... pretty clear, if you want to play in MEK spacscaram(o)uche-4/20/2010
74Three out on a limb projects, all neatly tucked away. Leaving meat to carve. Nscaram(o)uche-4/19/2010
73Array BioPharma Signs Strategic Oncology Collaboration sim1-4/19/2010
72Array BioPharma Announces Eight Abstracts Selected for Presentation at 2010 AACRsim1-4/13/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News